Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Phillip Andrew Dennis currently holds 157,941 shares of NovaBridge Biosciences (NBP), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Phillip Andrew Dennis has been a net seller of NBP stock. They have purchased $0 and sold $5.6K worth of shares.
Phillip Andrew Dennis's most recent insider trade was on Jun 18, 2026, when they sold 8,494 shares at $0.66 per share.
Phillip Andrew Dennis serves as Chief Medical Officer at NovaBridge Biosciences (NBP). They have executed 3 insider transactions totaling $5.6K over their tenure at the company.
Phillip Andrew Dennis holds the position of Chief Medical Officer at NovaBridge Biosciences, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Phillip Andrew Dennis has shown a selling trading pattern, with $0 in total purchases and $5.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Phillip Andrew Dennis was on Jun 18, 2026, when they sold $5.6K worth of NBP shares. This transaction involved 8,494 shares at $0.66 per share.
Phillip Andrew Dennis currently owns 157,941 shares of NovaBridge Biosciences (NBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Phillip Andrew Dennis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Phillip Andrew Dennis has 3 Form 4 filings on record as an insider at NovaBridge Biosciences.
Set alerts for Phillip Andrew Dennis and 40,000+ other insiders.